Table 6.
Materials | Design of the Device | Drug | Role of the Materials | References |
---|---|---|---|---|
EVA-PVA | Reservoir surrounded by a membrane | Glancicovir | EVA: membrane to limit the surface area for the permeability of the medication PVA: frame that regulates the rate of drug permeability |
[8,9,14,15,16,17,18] |
PVA-Silicone | Tablet geometry | FA | PVA: suture tab and coating Silicone: coating |
[16,17,33,34,35,36,37,38,39] |
PVA | Cylinder | FA | PVA: caps to regulate drug release rate | [40] |
PVA-PMMA-Silicone | Ring | Avastin | PVA: polymeric carrier to control release and stability of the drug PMMA: reservoir material Silicone: check valves for refilling |
[41] |
Titanium-PVA-EVA | Helix | TA | Titanium-PVA-EVA: reservoir | [14,42] |
PU-CNPs-PCL | DXM | PU: base material CNPs: as additive to modify mechanical properties PCL: as soft segment to improve polymer degradation, biocompatibility and stability |
[57] | |
PI-PVA-Silicone | Tubular | - | PI: base material PVA: membrane Silicone: adhesive plug |
[63] |
PCL | - | TA, 5-FU, DXM | PCL: carrier | [80,81,82] |
PLA | Disc | TA | PLA: base material | [92] |
PLGA-HPMC | Rod | DXM | PLGA-HPMC: base material | [35,108,109,110] |